The Journal of Urology
Volume 181, Issue 3 , Pages 1098-1103 , March 2009

Lycopene for Advanced Hormone Refractory Prostate Cancer: A Prospective, Open Phase II Pilot Study

Received 21 July 2008

References 

  1. Sternberg CN. Systemic treatment and new developments in advanced prostate cancer. Eur J Cancer. 2001;37:147
  2. Matlaga BR, Hall MC, Stindt D, Torti FM. Response of hormone-refractory prostate cancer to lycopene. J Urol. 2001;166:613
  3. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995;87:1767
  4. Aebischer CP, Schierle J, Schüep W. Simultaneous determination of retinol, tocopherols, carotene, lycopene, and xanthophylls in plasma by means of reversed-phase high-performance liquid chromatography. Meth Enzymol. 1999;299:348
  5. Newling DW. Criteria for response to treatment of metastatic prostatic cancer. Prog Clin Biol Res. 1985;185A:205
  6. American Society for Radiology and Oncology Consensus Statement. Guidelines for PSA following radiation therapy. Int J Radiat Biol. 1997;37:1035
  7. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–144
  8. Cohn W, Thürmann P, Tenter U, Aebischer C, Schierle J, Schalch W. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur J Nutr. 2004;43:304–312
  9. Smith DC, Dunn RL, Strawderman MS, Pienta KJ. Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer. J Clin Oncol. 1998;16:1835
  10. Bubley GJ, Carducci M, Dawson N, Daliani D, Eisenberger M, Figg WD, et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 1999;11:3461
  11. Scher HI, Kelly WM, Zhang ZF, Ouyang P, Sun M, Schwartz M, et al. Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer. J Natl Cancer Inst. 1999;91:244
  12. Small EJ, McMillan A, Meyer M, Chen L, Slichenmyer WJ, Lenehan PF, et al. Serum prostate-specific antigen decline as a marker of clinical outcome in hormone-refractory prostate cancer patients: association with progression-free survival, pain end points, and survival. J Clin Oncol. 2001;19:1304
  13. Ansari MS, Gupta NP. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol Oncol. 2004;22:415
  14. Clark PE, Hall MC, Borden LS, Miller AA, Hu JJ, Lee WR, et al. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 2006;67:1257
  15. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epididemiol. 2001;10:861
  16. Ansari MS, Gupta NP. A comparison of lycopene and orchiectomy vs orchiectomy alone in the management of advanced prostate cancer. BJU Int. 2003;92:375
  17. Miller JI, Ahmann FR, Drach GW, Emerson SS, Bottaccini MR. The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer. J Urol. 1992;147:956
  18. Isaacs JT, Coffey DS. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res. 1981;41:5070
  19. Schröder FH, Roobol MJ, Boeve ER, de Mutsert R, Zuijdgeest-van Leeuwen SD, Kersten I, et al. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol. 2005;48::922

 Study received Witten/Herdecke University ethics committee approval.

 Supported by the Bergisch Urologische Gesellschaft e. V. and Helios Kliniken GmbH, Berlin.

 For another article on a related topic see page 1393.

PII: S0022-5347(08)03039-5

doi: 10.1016/j.juro.2008.11.012

The Journal of Urology
Volume 181, Issue 3 , Pages 1098-1103 , March 2009

Article Tools

* Image Usage & Resolution